CLX’s price movements
Clorox (CLX) has a market cap of $16.5 billion. It fell 0.77% to close at $123.09 per share on September 13, 2016. The stock’s weekly, monthly, and year-to-date (or YTD) price movements were -6.8%, -7.7%, and -1.2%, respectively, on the same day.
CLX is trading 5.4% below its 20-day moving average, 7.2% below its 50-day moving average, and 4.0% below its 200-day moving average.
Related ETF and peers
The SPDR S&P Dividend ETF (SDY) invests 1.1% of its holdings in Clorox. The ETF tracks a yield-weighted index of 50 dividend-paying companies from the S&P 1500 Composite Index that have increased dividends for at least 20 consecutive years. The YTD price movement of SDY was 13.5% on September 13, 2016.
The market caps of Clorox’s competitors are as follows:
Clorox has declared a dividend
Clorox has declared a regular quarterly dividend of $0.80 per share on its common stock. The dividend will be paid on November 14, 2016, to shareholders of record at the close of business on October 26, 2016.
Performance of Clorox in fiscal 4Q16 and fiscal 2016
Clorox reported fiscal 4Q16 net sales of $1.6 billion, a rise of 2.8% compared to $1.56 billion in fiscal 4Q15. Sales for its Cleaning, Household, and Lifestyle segments rose 6.0%, 5.0%, and 3.7%, respectively, and sales for its International segment fell 8.6% in fiscal 4Q16 compared to fiscal 4Q15. The company’s gross profit margin fell 0.36% in fiscal 4Q16 compared to the prior year’s period.
Its net income and EPS (earnings per share) fell to $165.0 million and $1.26, respectively, in fiscal 4Q16 compared to $191.0 million and $1.46, respectively, in fiscal 4Q15.
Fiscal 2016 results
In fiscal 2016, CLX reported net sales of $5.8 billion, a rise of 1.8% YoY (year-over-year). The company’s gross profit margin rose 2.2% in fiscal 2016.
Its net income and EPS rose to $648.0 million and $4.92, respectively, in fiscal 2016 compared to $580.0 million and $4.37, respectively, in fiscal 2015. It reported non-GAAP (generally accepted accounting principles) EBITDA (earnings before interest, tax, depreciation, and amortization) of $1.2 billion in fiscal 2016, a rise of 3.8% YoY.
Clorox’s cash and cash equivalents and inventories rose 5.0% and 15.1%, respectively, in fiscal 2016. Its current ratio fell to 0.95x in fiscal 2016 compared to 1.0x in fiscal 2015. It reported non-GAAP free cash flow of $596.0 million in fiscal 2016, a fall of 18.7% YoY.
Clorox (CLX) has made the following projections for fiscal 2017:
- sales growth of 2%–4%, or 4%–6% excluding the 2% impact of unfavorable foreign currency exchange rates
- EPS of $5.38–$5.58, including the benefit of about $0.25–$0.30 from its adoption of Accounting Standards Update 2016-09
- EBIT (earnings before interest and tax) margin expansion of 0.25%–0.50%
- effective tax rate of 30%–31%
In the next part of the series, we’ll take a look at Under Armour (UA).